Pro Medicus Limited Updates on Market Buy-Back Program

Story Highlights
  • Pro Medicus Limited specializes in radiology information systems and medical imaging software.
  • The company announced an update on its on-market buy-back program, repurchasing 1,250 securities recently.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Pro Medicus Limited Updates on Market Buy-Back Program

An announcement from Pro Medicus Limited ( (AU:PME) ) is now available.

Pro Medicus Limited has announced an update regarding its ongoing on-market buy-back program. The company has repurchased a total of 27,076 ordinary fully paid securities before the previous day and an additional 1,250 securities on the previous day. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value.

More about Pro Medicus Limited

Pro Medicus Limited operates in the healthcare technology industry, specializing in the development and provision of radiology information systems and medical imaging software solutions. The company focuses on delivering innovative products that enhance the efficiency and effectiveness of medical imaging processes, catering to healthcare providers and institutions.

YTD Price Performance: -16.19%

Average Trading Volume: 479

Technical Sentiment Signal: Sell

Current Market Cap: $13.26B

Learn more about PME stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App